ALEC stock forecast
Our latest prediction for Alector Inc's stock price was made on the Sept. 23, 2021 when the stock price was at 24.26$.
In the short term (2weeks), ALEC's stock price should underperform the market by -2.72%. During that period the price should oscillate between -10.89% and +10.15%.
In the medium term (3months), ALEC's stock price should underperform the market by -6.58%. During that period the price should oscillate between -39.21% and +24.60%.Get email alerts
Create a solid portfolio with ALEC
About Alector Inc
Alector is a clinical stage biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegenerative diseases. The Company is developing a broad portfolio of innate immune system programs, designed to functionally repair genetic mutations that cause dysfunction of the brain's immune system and enable the rejuvenated immune cells to counteract emerging brain pathologies. Immuno-neurology targets immune dysfunction as a root cause of multiple pathologies that are drivers of degenerative brain disorders. The Company's immuno-neurology product candidates are supported by biomarkers and target genetically defined patient populations in frontotemporal dementia and Alzheimer's disease. This scientific approach is also the basis for the Company's immuno-oncology programs.
At the moment the company generates 21M USD in revenues.
On its last earning announcement, the company reported a loss of -2.69$ per share.
The book value per share is 3.86$
Three months stock forecastSept. 23, 2021
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|